Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
KRYS | C | Krystal Biotech, Inc. | -0.03 | |
MEDP | C | Medpace Holdings, Inc. | -0.33 | |
SRPT | C | Sarepta Therapeutics, Inc. | -0.71 | |
DCTH | C | Delcath Systems, Inc. | 0.00 | |
MORF | C | Morphic Holding, Inc. | 1.76 | |
ORGS | C | Orgenesis Inc. | 3.31 | |
GH | C | Guardant Health, Inc. | -1.59 | |
NXTC | C | NextCure, Inc. | 4.67 | |
NBIX | C | Neurocrine Biosciences, Inc. | 0.54 | |
NVAX | C | Novavax, Inc. | -3.24 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Biopharmaceutical
Biotechnology
Organ Systems
Pain
Antibodies
Cancer
Cholesterol
Clinical Research
Medical Research
Monoclonal Antibodies
S&P 500
Technology Products
Tumor
Tyrosine Kinase Receptors
Acute Intermittent Porphyria
Alnylam Pharmaceuticals
Alpha 1 Antitrypsin Deficiency
Alzheimer's Disease
Amyloid
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PSIL | F | AdvisorShares Psychedelics ETF | 3.07 | |
BBP | C | BioShares Biotechnology Products Fund | 3.0 | |
LABD | F | Direxion Daily S&P Biotech Bear 3X Shares | 2.85 | |
PBE | B | PowerShares Dynamic Biotech & Genome | 2.37 | |
BIS | D | ProShares UltraShort Nasdaq Biotechnology | 0.95 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Cancer
Biotechnology
Life Sciences
Monoclonal Antibody
Treatment Of Cancer
Biology
Drug Discovery
Immune Checkpoint
Immunology
Medicine
Monoclonal Antibodies
Sarcoma
Solid Tumors
Acute Myeloid Leukemia
Adjunctive Therapy
Anemia
Anti Cancer Therapies
Antibody
Antibody Drug Conjugate
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles